1. Home /
  2. Pharmaceuticals


Options Play of the Week: Take a Chance on This Small Biopharma in 2022

After a huge drop in recent weeks, these shares look oversold -- and an insider seems to agree.

Gilead Sciences Is Poised for Still Further Gains

We have three new price targets.

Amgen's Charts Continue to Strengthen

This rally could surprise on the upside.

I Don't Love Biogen, But Here's How to Trade It

I'm not saying get married to the stock, I'm saying that the idea could be a trade based on two possible catalysts.

So Far, So Good for This Portfolio of Unloved Losers

Most of the stocks in the 2022 Tax Loss Selling Recovery Portfolio are in positive territory nearly a month since inception.

Shares of Amgen Are Finally Beginning to Turn Around

We have a new price target for now.

Beaten-Down Biogen Could Finally Be Reaching an 'Interesting' Level

The shares have been cut in half over the last six months.

BioDelivery Sciences Is My Stock Pick for 2022

A successful launch of ELYXYB, solid revenue growth and increasing cash flow seems on the horizon.

Here's Our Best Dividend Stock for 2022

Blue chip stock Bristol-Myers Squibb has a high dividend yield and an excellent pipeline.

AstraZeneca Is Ready to Rally Again Based on the Chart Pattern

But broadening patterns can be tricky to trade.